scholarly journals Expanding transcatheter aortic valve implantation to younger, lower-risk patients?

2012 ◽  
Vol 144 (2) ◽  
pp. 522
Author(s):  
Marjan Jahangiri ◽  
Gopal Soppa
2012 ◽  
Vol 366 (18) ◽  
pp. 1705-1715 ◽  
Author(s):  
Martine Gilard ◽  
Hélène Eltchaninoff ◽  
Bernard Iung ◽  
Patrick Donzeau-Gouge ◽  
Karine Chevreul ◽  
...  

Author(s):  
Suvitesh Luthra ◽  
Sunil K Ohri

The PARTNER 3 and Evolut LRT trials have provided the evidence base for transcatheter aortic valve implantation in low-risk patients. However, there are still issues with durability, long-term follow up and complications before their widespread use can be considered appropriate in this group.


2012 ◽  
Vol 59 (3) ◽  
pp. 280-287 ◽  
Author(s):  
Ruediger Lange ◽  
Sabine Bleiziffer ◽  
Domenico Mazzitelli ◽  
Yacine Elhmidi ◽  
Anke Opitz ◽  
...  

2021 ◽  
Vol 4 (3) ◽  
pp. 157-161
Author(s):  
Yan Xu ◽  
Pengkun Zhang ◽  
Dengfeng Fang

Surgical aortic valve replacement (SAVR) is considered the gold-standard treatment for patients with severe aortic valve stenosis (AS), yet 30% are considered inappropriate for SAVR on account of the advanced age and multiple comorbidities. Transcatheter aortic valve implantation (TAVI) provides an option for high-risk patients with severe AS, especially for those accompanied with acute cardiogenic shock and multiple organ dysfunction. Herein, we presented a case of a patient resuscitated successfully with TAVI in combination with intra-aortic balloon pump.


Sign in / Sign up

Export Citation Format

Share Document